FIELD: chemistry.
SUBSTANCE: present invention relates to a method for producing a polymorphic form of [5-fluorine-3-({2-[(4-fluorobenzene)sulfonyl]pyridine-3-yl}methyl)-2-methylindole-1-yl]-acetic acids. Method for producing the polymorphic form 2 of [5-fluorine-3-({2-[(4-fluorobenzene)sulfonyl]pyridine-3-yl}methyl)-2-methylindole-1-yl]acetic acid (compound 1) is characterized by Raman spectrum with Fourier transformation with characteristic peaks at 3063 ± 2 cm-1, 1578 ± 2 cm-1, 1423 ± 2 cm-1, 1209 ± 2 cm-1, 1187 ± 2 cm-1, 1166 ± 2 cm-1, 1150 ± 2 cm-1, 930 ± 2 cm-1, 883 ± 2 cm-1, 770 ± 2 cm-1, 356 ± 2 cm-1, 304 ± 2 cm-1, 167 ± 2 cm-1, 119 ± 2 cm-1 or the following crystal lattice parameters:
The method is carried out by (a) suspending compound 1 in a solvent containing acetonitrile, a mixture of acetonitrile and water or a ketone solvent selected from methyl isobutyl ketone, methyl ethyl ketone and mixtures thereof, wherein compound 1 is in an amorphous form, in a crystalline form other than polymorphic form 2, or in the form of a mixture of polymorphic form 2 with one or more other polymorphic forms; (b) mixing the suspension at a temperature of about 15 to 25 °C for 15 to 30 days; and (c) separating and drying the solid [5-fluorine-3-({2-[(4-fluorobenzene)sulfonyl]pyridine-3-yl}methyl)-2-methylindole-1-yl]acetic acid. The invention also relates to a method for producing a polymorphic form of 2 [5-fluorine-3-({2-[(4-fluorobenzene)sulfonyl]pyridine-3-yl}methyl)-2-methylindole-1-yl]acetic acid (compound 1) by obtaining a saturated solution of compound 1 in a solvent selected from acetonitrile, acetonitrile and water or a ketone solvent selected from methyl isobutyl ketone, methyl ethyl ketone or a mixture thereof; seeding the specified saturated solution with crystals of the polymorphic form 2 of compound 1; holding with crystallization; and separating crystals of polymorphic form 2 of compound 1.
EFFECT: production of a thermodynamically stable polymorphic form of 2 [5-fluorine-3-({2-[(4-fluorobenzene)sulfonyl]pyridine-3-yl}methyl)-2-methylindole-1-yl]acetic acid.
6 cl, 18 dwg, 3 tbl, 9 ex
Authors
Dates
2021-07-13—Published
2015-05-01—Filed